Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013943-13
Application #
4690423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Roger Williams Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
Trunzo, Joseph J; Pinto, Bernardine M (2003) Social support as a mediator of optimism and distress in breast cancer survivors. J Consult Clin Psychol 71:805-11
Pinto, Bernardine M; Trunzo, Joseph J; Reiss, Philip et al. (2002) Exercise participation after diagnosis of breast cancer: trends and effects on mood and quality of life. Psychooncology 11:389-400
Wanebo, H J; Belliveau, J F (1999) A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43:427-34
Oguey, D; Dumenco, L L; Pierce, R H et al. (1996) Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology 24:1024-33
Elenitoba-Johnson, K S; Medeiros, L J; Khorsand, J et al. (1996) P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 106:728-38
Davol, P; Frackelton Jr, A R (1996) The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model. J Urol 156:1174-9
Wolf, D A; Wang, S; Panzica, M A et al. (1996) Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56:5012-22
Cheng, J C; Frackelton Jr, A R; Bearer, E L et al. (1995) Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells. Cell Growth Differ 6:139-48
Dumenco, L; Oguey, D; Wu, J et al. (1995) Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology 22:1279-88
Lee, S E; Pulaski, C R; He, D M et al. (1995) Isolation of mammalian cell mutants that are X-ray sensitive, impaired in DNA double-strand break repair and defective for V(D)J recombination. Mutat Res 336:279-91

Showing the most recent 10 out of 34 publications